You are here

  • Home
  • Archive
  • Volume 20, Issue Suppl 1
  • GRP-176 Study of the Importance of the Pharmaceutical Contribution in the Detection of Non Conformity (NC) in the Medication Process in Chemotherapy

Article info

Article menu

Download PDFPDF

General and risk management, patient safety
GRP-176 Study of the Importance of the Pharmaceutical Contribution in the Detection of Non Conformity (NC) in the Medication Process in Chemotherapy
Free

Authors

Citation

Renaud A, Duprès M, Aubert J, et al
GRP-176 Study of the Importance of the Pharmaceutical Contribution in the Detection of Non Conformity (NC) in the Medication Process in Chemotherapy
European Journal of Hospital Pharmacy 2013;20:A63.

Publication history

  • First published March 12, 2013.
Online issue publication 
October 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions